Randomized pilot study of optimal dose period for indisetron tablets for preventing chemotherapy-induced nausea and vomiting with mFOLFOX6: HGCSG0703
Ontology highlight
ABSTRACT: Interventions: 3-day indisetron regimen
1-day indisetron regimen
Primary outcome(s): Complete protection from vomiting
Study Design: Parallel Randomized
DISEASE(S): Colorectal Cancer
PROVIDER: 2632889 | ecrin-mdr-crc |
REPOSITORIES: ECRIN MDR
ACCESS DATA